<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Oncology on VXB US</title>
    <link>https://www.vxbus.com/tags/oncology/</link>
    <description>Recent content in Oncology on VXB US</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en</language>
    <copyright>© 2026 </copyright>
    <lastBuildDate>Fri, 19 Jun 2026 22:54:56 +0800</lastBuildDate><atom:link href="https://www.vxbus.com/tags/oncology/index.xml" rel="self" type="application/rss+xml" />
    
    <item>
      <title>Syndecan-4 (SDC4) in Cancer Metastasis: A Promising Therapeutic Target</title>
      <link>https://www.vxbus.com/news/syndecan-4-sdc4-in-cancer-metastasis-a-promising-therapeutic-target/</link>
      <pubDate>Fri, 19 Jun 2026 22:54:56 +0800</pubDate>
      
      <guid>https://www.vxbus.com/news/syndecan-4-sdc4-in-cancer-metastasis-a-promising-therapeutic-target/</guid>
      <description></description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://www.vxbus.com/news/syndecan-4-sdc4-in-cancer-metastasis-a-promising-therapeutic-target/featured-SDC4_regulates_tumor_cell_survival.jpeg" />
    </item>
    
    <item>
      <title>NETs in Cancer: How Neutrophil Traps Shape Tumor Fate</title>
      <link>https://www.vxbus.com/medical/nets-in-cancer-how-neutrophil-traps-shape-tumor-fate/</link>
      <pubDate>Tue, 05 May 2026 10:40:04 +0800</pubDate>
      
      <guid>https://www.vxbus.com/medical/nets-in-cancer-how-neutrophil-traps-shape-tumor-fate/</guid>
      <description></description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://www.vxbus.com/medical/nets-in-cancer-how-neutrophil-traps-shape-tumor-fate/featured-Neutrophil_traps_drive_tumor_growth.jpeg" />
    </item>
    
    <item>
      <title>J&amp;J Acquires Halda Therapeutics for $3.05B</title>
      <link>https://www.vxbus.com/news/johnson-and-johnson-acquires-halda-therapeutics-for-3.05-billion/</link>
      <pubDate>Tue, 30 Dec 2025 22:31:31 +0800</pubDate>
      
      <guid>https://www.vxbus.com/news/johnson-and-johnson-acquires-halda-therapeutics-for-3.05-billion/</guid>
      <description></description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://www.vxbus.com/news/johnson-and-johnson-acquires-halda-therapeutics-for-3.05-billion/featured-Johnson-and-johnson-acquires-halda.png" />
    </item>
    
    <item>
      <title>Sanofi’s AlphaMedix Hits Key Efficacy Goals in Phase 2 Neuroendocrine Tumor Trial</title>
      <link>https://www.vxbus.com/news/sanofis-alphamedix-hits-key-efficacy-goals-in-phase-2-neuroendocrine-tumor-trial/</link>
      <pubDate>Thu, 09 Oct 2025 20:08:06 +0800</pubDate>
      
      <guid>https://www.vxbus.com/news/sanofis-alphamedix-hits-key-efficacy-goals-in-phase-2-neuroendocrine-tumor-trial/</guid>
      <description></description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://www.vxbus.com/news/sanofis-alphamedix-hits-key-efficacy-goals-in-phase-2-neuroendocrine-tumor-trial/featured-Sanofi-AlphaMedix.png" />
    </item>
    
    <item>
      <title>Ozempic and Cancer: Exploring GLP-1 Drugs’ Potential in Oncology</title>
      <link>https://www.vxbus.com/news/ozempic-and-cancer-exploring-glp-1-drugs-potential-in-oncology/</link>
      <pubDate>Mon, 22 Sep 2025 22:02:51 +0800</pubDate>
      
      <guid>https://www.vxbus.com/news/ozempic-and-cancer-exploring-glp-1-drugs-potential-in-oncology/</guid>
      <description></description>
      <media:content xmlns:media="http://search.yahoo.com/mrss/" url="https://www.vxbus.com/news/ozempic-and-cancer-exploring-glp-1-drugs-potential-in-oncology/featured-GLP-1-drug.jpeg" />
    </item>
    
  </channel>
</rss>
